The Victoria’s Secret Global Fund for Women’s Cancers - Awards

In Partnership with Pelotonia

Career Development Awardees

  • Sarah E. Johnstone, MD, PhD

    Dana-Farber Cancer Institute, to develop novel theraputic approaches to gynecologic cancers

    //images.ctfassets.net/rl584me0mmso/5YbzKmFN36Dd9RJWwI7g64/9e8e7b961b047b6d3dfcadc6f8219604/Johnstone_Headshot.jpg
  • Purna Joshi, PhD

    The University of Texas at Dallas, to develop improved screening tools and effective interventions to tackle obesity-associated breast cancer

    //images.ctfassets.net/rl584me0mmso/46uLr7u8A36g5ya031tdEQ/35d49f6c313fd8724469fb705cb802b4/Purna_Joshi_Portrait.png
  • Angelina Regua, PhD

    The University of Texas Health Science Center at Houston, to identify effective treatments for patients with triple-negative breast cancer that develop breast cancer brain metastases

    //images.ctfassets.net/rl584me0mmso/5nW9P2I92yEcQj32IhDAnp/87912310896585d70ea1e703467efdab/ARegua_headshot.jpg
  • Ana Ruiz-Saenz, PhD

    Center for Cooperative Research in Biosciences (CIC bioGUNE), to improve the efficacy of treatments for all breast cancer patients

    //images.ctfassets.net/rl584me0mmso/4iaJk1gr9wZLB018pFmomS/bdfafbce57911f004ebbe1d89b2b2b0e/Untitled_design.png
  • Read More about the 2023 Career Development Awardees

Career Development Awards foster innovation in the understanding, prevention, interception, early detection, diagnosis, and treatment of breast and gynecologic cancers with the goal of eliminating cancer health disparities and improving patient outcomes.

2023 Rising Innovator Grantees

  • Priscilla K. Brastianos, MD

    The Mass General Cancer Center, to identify drivers of brain metastasis from breast cancer

    //images.ctfassets.net/rl584me0mmso/1mfxlMzi1JRakAYGB1OA8h/733bda36841ff159cf6b0cbdd169596b/Priscilla_Brastianos_photo.jpg
  • Kemi M. Doll, MD, MCSR

    University of Washington, to study the dissemination tool of biopsy-first early detection of endometrial cancer

    //images.ctfassets.net/rl584me0mmso/5LL9rwvRFm6yA1Yb9GjZA1/219198bd8049b25eeba0e7ccfd58eadd/Kemi_Doll_photo.jpg
  • Marleen Kok, MD, PhD

    The Netherlands Cancer Institute, Netherlands, to study single cell analyses of immunotherapy responses in triple negative breast cancer

    //images.ctfassets.net/rl584me0mmso/6RQQ3drwdKovnbcqEWTdzL/c3b8b27fb08e8f8abecba259e0e2f3c3/Marleen_Kok_photo.png
  • Joyce Liu, MD

    Dana-Farber Cancer Institute, to advance targeted therapies for high-grade endometrial cancer

    //images.ctfassets.net/rl584me0mmso/22gnb7BFgF8MXku2Crziq2/dd7365c2e91bea6fb4f972cdfed96042/Joyce_Liu_SOG_0490_08.jpg
  • Sandra S. McAllister, MD

    The Brigham and Women’s Hospital, to eliminate age-and race-based disparities in breast cancer outcomes

    //images.ctfassets.net/rl584me0mmso/h1RNbXJf5e0b1NMaeNUxA/773e6362f694c971d5c6bd64681c4514/McAlliister_photo.jpg
  • Read more about the 2023 Rising Innovator Grantees

Rising Innovator awards are presented to mid-career scientists working to pursue innovative research projects in breast and gynecologic cancers.

2022 Career Development Awardees

  • Valentina Hoyos Velez, MD

    Baylor College of Medicine Center for Cell and Gene Therapy, Dan L Duncan Comprehensive Cancer Center, to advance the treatment of triple negative breast cancer

    //images.ctfassets.net/rl584me0mmso/4i6seQt1cMhZ25m6ruMJlQ/d38e3e1a502d584098dc224cbe4157ce/Valentina_Hoyos_Velez_headshot.jpg
  • Martina McDermott, PhD

    The Regents of the University of California, Los Angeles, to develop a novel therapy designed to target ovarian and endometrial cancers

    //images.ctfassets.net/rl584me0mmso/2v1iXP9UpAiQPK7f5x4sxy/3b1b78626c86548d70f09fdcae299b9d/MartinaMcDermott_headshot.jpg
  • Chemtai Mungo, MD, MPH, FACOG

    University of North Carolina at Chapel Hill Department of Obstetrics and Gynecology, to improve the prevention of cervical cancer among women living with HIV in Sub-Saharan Africa

    //images.ctfassets.net/rl584me0mmso/3Qvrpr2PCz98I2nWxZMnvh/1420e42e923e30e43e4b6d263557b887/Chemtai_Mungo_headshot.jpg
  • Mya Roberson, PhD, MSPH

    University of North Carolina at Chapel Hill Gillings School of Global Public Health, to improve the genetic testing and treatment trajectories for hereditary breast and ovarian cancers in black women

    //images.ctfassets.net/rl584me0mmso/6QjnDShelOk8MLo3MlQ0W5/e55ebfd6d43c0702f13e82d3b5bb5f4b/692.jpg
  • Shuang Zhang, PhD

    The Third Affiliated Hospital of Guangzhou Medical University, China, to advance the understanding of high-grade serous ovarian cancer to improve treatment outcomes

    //images.ctfassets.net/rl584me0mmso/zbj58w9xuoXY4wCRJlHu0/e464a7680b8b07bfa268f305f71a13c4/Shuang_Zhang_headshot.jpg
  • Read more about the 2022 Career Development Awardees

Career Development Awards foster innovation in the understanding, prevention, interception, early detection, diagnosis, and treatment of breast and gynecologic cancers with the goal of eliminating cancer health disparities and improving patient outcomes.

2022 Meritorious Awardees

  • Joan S. Brugge, PhD, FAACR

    Ludwig Center, Harvard Medical School, for her lifelong investigations dedicated to unraveling the mechanisms that initiate cancer, its progression and resistance to drugs

    //images.ctfassets.net/rl584me0mmso/4I0F6eJ90NoQV86yAjbjqC/3c19d1b5f4a13498eb918b80528b4cd1/joan_brugge.jpg
  • Susan M. Domchek, MD

    Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, for her international expertise in genetic testing to determine cancer susceptibility

    //images.ctfassets.net/rl584me0mmso/5ViJf0NwPEaBP9UZzItUKt/1cccd5e1bef49c923a901badeae6f0b6/susan_domchek.jpg
  • Karen H. Lu, MD

    The University of Texas MD Anderson Cancer Center, for her fundamental studies on the identification on tissue biomarkers and the prevention of endometrial cancer in women with Lynch Syndrome

    //images.ctfassets.net/rl584me0mmso/5aO9zsUIsH4ICZbTeDtcfr/595d3354888fd0e7e03cb63e5f17bc01/karen_lu.jpg
  • Lisa A. Newman, MD, MPH

    New York-Presbyterian/Weill Cornell Medical Center, for advancing the understanding of the causes of breast cancers in African and African American women

    //images.ctfassets.net/rl584me0mmso/3hrPAE0WNm5jOFori9NlsD/9a0236e15229234f85c1393641a9fad4/lisa_newman.jpg
  • Martine J. Piccart, MD, PhD, FAACR

    Université Libre de Bruxelles, Belgium, for her leadership in advancing breast cancer clinical trials and drug development

    //images.ctfassets.net/rl584me0mmso/64ANdFchC36vEBmfi0M7m9/9d2568160c3a7e693bb390aad9e57e02/martine_piccart.jpg
  • Read more about the 2022 Meritorious Award recipients

Meritorious Awards are presented to five female cancer researchers to recognize and further their outstanding contributions to the field of women’s cancers.

Scientific Advisory Committee

The Scientific Advisory Committee is composed of an international group of cancer research experts appointed by the AACR in collaboration with Pelotonia and The Victoria’s Secret Global Fund for Women’s Cancers.

100% of participant-raised funds go to innovative cancer research.

450 W. Broad Street, Columbus, OH | 614.221.6100

© 2024 Pelotonia. All rights reserved.

Major Funding Partners